CREB1 and melanoma: (97) showed that deletion of Mettl3 specifically in CD4+ and CD8+ T cells disturb the stability of the Creb1 transcript, which in turn controls the protein and phosphorylation levels of Creb1, inhibiting iNKT cell proliferation, differentiation, and cytokine secretion, ultimately causing defects in B16F10 melanoma resistance.